Aicaigou LogoB2B Wiki

Pharmaceutical Sucrose

Updated: 2026-08-20

Overview

Pharmaceutical sucrose is a disaccharide carbohydrate refined to meet strict pharmacopeial standards (USP, EP, JP). Unlike food-grade sucrose, it undergoes additional purification to remove impurities like ash, colorants, and microbial contaminants. The pharmaceutical industry accounts for approximately 12% of global specialty sucrose production. Its primary role in drug formulations includes masking bitter tastes in oral medications (especially pediatric syrups) and providing bulk in tablet compression. Recent advances have expanded its use in biopharmaceuticals as a cryoprotectant for stabilizing vaccines and monoclonal antibodies during lyophilization.

Physical and Chemical Properties

Pharmaceutical sucrose exhibits identical molecular structure to regular sucrose but with tighter control over particle size distribution (typically 150-500 µm) and crystallinity. Its high purity ensures minimal reactivity with APIs – a critical requirement for drug stability. The material shows negative deviation from Raoult's Law in aqueous solutions, making it effective for osmotic drug delivery systems. Key testing parameters per pharmacopeias include: specific rotation (+66.3° to +67.0°), conductivity (≤50 µS/cm for EP grade), and absence of reducing sugars (limit ≤0.1%). The crystalline form is monoclinic (space group P21), contributing to excellent compressibility in direct compression tablet formulations.

Main Applications

In oral solid dosages, sucrose serves as a binder (10-25% w/w) in wet granulation and as a diluent in chewable tablets. Liquid formulations utilize its syrup form (67% w/v) for viscosity enhancement and taste masking. Emerging applications include: 1. Lyophilization: Protects protein structure during freeze-drying (5-10% concentration) 2. Biologic stabilizer: Maintains vaccine potency in cold chain logistics 3. Osmotic agent: In peritoneal dialysis solutions and some IV preparations 4. Coating substrate: For sugar-coated tablets requiring gradual drug release

Safety and Storage

While generally recognized as safe (GRAS), pharmaceutical sucrose requires careful handling in bulk powder form due to explosion risks (minimum ignition energy = 30 mJ). Facilities must comply with ATEX directives for dust explosion prevention. Storage areas should maintain relative humidity below 65% to prevent caking. Regulatory documentation should include: Certificate of Analysis (heavy metals ≤5 ppm, sulfated ash ≤0.1%), microbial limits (TAMC ≤1000 CFU/g, TYMC ≤100 CFU/g), and absence of Salmonella/E. coli. For sterile applications, gamma-irradiated grades (25 kGy) are available with validated sterility assurance levels (SAL 10⁻⁶).

B2B Procurement Guide

Pharmaceutical manufacturers should prioritize suppliers with: 1. GMP certification specifically for excipient production (not just food-grade facilities) 2. Validated supply chain documentation (GDP compliance) 3. Batch traceability including sugar beet/cane origin (important for allergen declarations) Technical specifications to verify: particle size distribution (critical for flow properties), water content (≤0.1% for lyophilization use), and residual solvent testing if ethanol is used in crystallization. For large-volume procurement (10+ metric tons), consider contractual agreements for stability testing retention samples.

Related Manufacturers